Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
Stephen CaldwellRobert J WongJeremy FraysseSanatan ShreaySuying LiStephen HarrisonStuart C GordonPublished in: Alimentary pharmacology & therapeutics (2020)
The present report (a) demonstrates that NAFLD is grossly underdiagnosed in real-world clinical settings and (b) provides new evidence on the progression rates of NAFLD and risk factors of mortality across the spectrum of severity of NAFLD and cirrhosis.